from The Century Dictionary.
- noun A Roman gold coin equivalent to 100 sesterces or 25 denarii, first minted in the first century
b. c., and issued under the empire till the reign of Constantine I., who substituted for it the gold solidus.
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun A
gold coinminted during the Roman Empirefrom approximately 100 B.C.to 309 A.D., equal to 25 denarii.
from Wiktionary, Creative Commons Attribution/Share-Alike License
Methicillin-resistant Staphylococcus aureus is an opportunist – any ‘opening’, for example: intro of an i.v. line; suture lines, etc. can become host to this ‘nasty bug’.
If someone studied the ability of, say, the human microcephalin gene to generate resistance to penicillin in S. aureus, and found that it never did even when extensively mutagenized, only a fool would conclude that this means that S. aureus is incapable of developing resistance to penicillin.
In the late Empire, it was hoped that new coins -- the silver "nummus" and the gold "aureus" -- would restore confidence during periods of devastating inflation.
Researchers were particularly interested to see how they coped with "superbugs" like MRSA methicillin-resistant Staphylococcus aureus, which is a big problem in many hospitals.
Three bedbugs collected from the other patient tested positive for the superbug MRSA methicillin-resistant Staphylococcus aureus, which is also resistant to antibiotics.
For example, spending problems began to be evident in the early years of the Roman Empire, and they became huge in the third century C.E. Perhaps as early as the third century B.C.E., Rome began minting a gold coin that came to be known as the aureus.
Staphylococcus aureus, which is the most common cause of skin and soft tissue infections such as cellulitis, have emerged and are creating a serious public health concern.
Likewise, they were able to combine data from the C. albicans group with data from a group of mice infected with Staphylococcus aureus, which is sometimes found in hospitalized patients.
The Company's development pipeline includes Phase II vaccine programs for Pseudomonas (in-house development) and S. aureus, which is being developed with Merck & Co. Inc.
The results on Tuesday showed it was an infection caused by methicillin-resistant Staphylococcus aureus, which is more commonly known as MRSA.